Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524774 | NSE Symbol : NGLFINE | ISIN : INE887E01022 | Industry : Pharmaceuticals - Indian - Bulk Drugs |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
30-Jan-2025	07-Feb-2025	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve Notice of Board Meeting Outcome of Board Meeting (As Per Bse Announcement Dated on 07.02.2025) With reference to email received from NSE that the updates of financial results was not in machine readable form. (As Per BSE Announcement Dated on 06.03.2025)
28-Oct-2024	08-Nov-2024	Quarterly Results	Quarterly Results Outcome of the Board Meeting (As Per BSE Announcement Dated on: 08/11/2024)
05-Aug-2024	12-Aug-2024	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve This is to inform you that the Second Board Meeting for the financial year 2024-25 of the Board of Directors of NGL Fine-Chem Limited will be held on Monday 12th August 2024 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June 2024. 2. Any other business with the permission of the chair. Financial Results for the quarter ended 30th June 2024 (As per BSE Announcement dated on 12/08/2024)
09-May-2024	21-May-2024	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 inter alia to consider and approve This is to inform you that the First Board Meeting for the financial year 2024-25 of the Board of Directors of NGL Fine-Chem Limited will be held on Tuesday 21st May 2024 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the Standalone & Consolidate Audited Balance Sheet as on 31st March 2024 the Statement of Profit & Loss Cash Flow Statement and statement of change in equity for the year ended on 31st March 2024 together with the schedules thereon. 2. To take on record the Auditors Report for the Financial Year 2023-2024. 3. To approve the Audited Standalone & Consolidated Financial Results for the quarter and year ended on 31st March 2024. 4. To approve the Statement of Assets & Liabilities for the year ended on 31st March 2024. 5. To approve the Statement of Cash flow for the year ended on 31st March 2024. Recommendation of final dividend Outcome of BM Dividend updates (As per BSE Announcement Dated on 21/05/2024)
11-Mar-2024	18-Mar-2024	Change in Directors	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/03/2024 inter alia to consider and approve appointment of Mr. Dhananjay Mungale (DIN: 00007563) as an Additional (Non-Executive) Independent Director of the Company including matters related / incidental thereto. This is to inform you that the fifth Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2023-2024 held today i.e. on Monday, 18th March, 2024, where in Board approved the following: - 1) Appointment of Mr. Dhananjay Mungale (DIN: 00007563) as an Independent Director of the Company for a term of 5 years w.e.f 18th March,2024 subject to shareholders' approval. 2) Notice of Postal Ballot by remote e-voting process for seeking approval of members for Appointment of Mr. Dhananjay Mungale (DIN: 00007563) as an Independent Director of the Company for a period of 5 years. 3) The record date for Postal Ballot will be Friday, 15th March, 2024. 4) Appointment of Mr. Hemant Shetye (Membership No. 2827 FCS No 1483) Practicing Company Secretary as Scrutinizer for conducting the remote e-voting process in a fair and transparent manner. 5) Appointment of CDSL for providing e-voting facility. (As Per BSE Announcement Dated on 18/03/2024)
03-Feb-2024	12-Feb-2024	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve This is to inform you that the Fourth Board Meeting for the financial year 2023-24 of the Board of Directors of NGL Fine-Chem Limited will be held on Monday 12th February 2024 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended on 31st December 2023. 2. Any other business with the permission of the chair. We request you to kindly take this information on record. This is to inform you that the fourth Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2023-2024 held today i.e. on Monday, 12th February, 2024, where in Board has approved the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Report issued by the Statutory Auditors of the Company. The aforesaid results are also being disseminated on Company''s website at www.nglfinechem.com. The meeting of the Board of Directors commenced at 5.30 p.m. and concluded at 6.35 p.m. Kindly take the same on your record. (As per BSE Announcement Dated on 12/02/2024)
02-Nov-2023	10-Nov-2023	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve This is to inform you that the third Board Meeting for the financial year 2023-24 of the Board of Directors of NGL Fine-Chem Limited will be held on Friday 10th November 2023 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the Unaudited Standalone & Consolidated Financial Results for the quarter ended on 30th September 2023. 2. Any other business with the permission of the chair. We request you to kindly take this information on record. This is to inform you that the third Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2023-2024 held today i.e. on Friday, 10th November, 2023, where in Board has approved the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30th September, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Report issued by the Statutory Auditors of the Company. The aforesaid results are also being disseminated on Company''s website at www.nglfinechem.com. The meeting of the Board of Directors commenced at 5.30 p.m. and concluded at 6.35 p.m. Kindly take the same on your record. (As per BSE Announcement Dated on 10/11/2023)
26-Jul-2023	04-Aug-2023	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 inter alia to consider and approve 1. The Unaudited Standalone & Consolidated Financial Results for the quarter ended on 30th June 2023. 2. Any other business with the permission of the chair. Outcome of the Board Meeting held on 4th August, 2023 (As Per BSE Announcement Dated on 04.08.2023)
05-May-2023	15-May-2023	Accounts	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2023 inter alia to consider and approve This is to inform you that the first Board Meeting for the financial year 2023-24 of the Board of Directors of NGL Fine-Chem Limited will be held on Monday 15th May 2023 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the Standalone Audited Balance Sheet as on 31st March 2023 the Statement of Profit & Loss Cash Flow Statement and statement of change in equity for the year ended on 31st March 2023 together with the schedules thereon. 2. To approve the Consolidated Audited Balance Sheet as on 31st March 2023 the Statement of Profit & Loss Cash Flow Statement and Statement of change in equity for the year ended on 31st March 2023 together with the schedules thereon. 3. To take on record the Auditors Report for the Financial Year 2022-2023. 4. To approve the Audited Standalone Financial Results for the quarter and year ended on 31st March 2023. Recommendation of final Dividend of Rs.1.75/- per fully paid up equity share of Rs.5/- each for the financial year ended on 31st March, 2023 Appointed HSPN & Associates LLP, Company Secretaries as the Secretarial Auditors of the Company for the financial year 2023-2024. Approved the appointment of M/s. Rach & Associates as Internal Auditors of the Company for the financial year 2023-24. A brief profile of Rach & Associates is enclosed herewith. This is to inform you that the First Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2023-2024 held on Monday, 15th May, 2023 at 301 E-Square, Subhash Road, Vile Parle East, Mumbai 400057 approved the following: 1. Audited Financial Results (Standalone& Consolidated) along with Statutory Auditor's Report for the quarter and year ended on 31st March, 2023 pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015. 2. Statement of Assets & Liabilities (Standalone & Consolidated) as on 31st March, 2023 This is to inform you that the First Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2023-2024 held on Monday, 15th May, 2023 at 301 E-Square, Subhash Road, Vile Parle East, Mumbai 400057 approved the following: 1. Audited Financial Results (Standalone& Consolidated) along with Statutory Auditor's Report for the quarter and year ended on 31st March, 2023 pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015. 2. Statement of Assets & Liabilities (Standalone & Consolidated) as on 31st March, 2023. 3. Recommendation of final Dividend of Rs.1.75/- per fully paid up equity share of Rs.5/- each for the financial year ended on 31st March, 2023. (As Per BSE Announcement Dated on 15.05.2023)
30-Jan-2023	10-Feb-2023	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve This is to inform you that the fifth Board Meeting for the financial year 2022-23 of the Board of Directors of NGL Fine-Chem Limited will be held on Friday 10th February 2023 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the unaudited Standalone Financial Results for the quarter & nine months ended on 31st December 2022. 2. To approve the unaudited Consolidated Financial Results for the quarter & nine months ended on 31st December 2022. 3. Any other business with the permission of the chair. We request you to kindly take this information on record. This is to inform you that the Fifth Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2022-2023 held on Friday, 10th February, 2023 at 301 E-Square, Subhash Road, Vile Parle East, Mumbai 400057 approved Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Report issued by the Statutory Auditors of the Company. The aforesaid results are also being disseminated on Company''s website at www.nglfinechem.com. The meeting of the Board of Directors commenced at 5.00 p.m. and concluded at 6.00 p.m. Kindly take the same on your record. (As Per BSE Announcement dated on 10.02.2023) Enclosed herewith please find revised outcome of the Board Meeting held on 10th February, 2023, please note that due to inadvertent error the outcome was printed on the plain paper instead of Letter head of the Company. There are no other changes. We once again submit the outcome on the letter head of the Company. Kindly take the same on your records. (As Per BSE Announcement dated on 13.02.2023)
19-Oct-2022	28-Oct-2022	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 inter alia to consider and approve This is to inform you that the fourth Board Meeting for the financial year 2022-23 of the Board of Directors of NGL Fine-Chem Limited will be held on Friday 28th October 2022 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the unaudited Standalone Financial Results for the quarter & half year ended on 30th September 2022. 2. To approve the unaudited Consolidated Financial Results for the quarter & half year ended on 30th September 2022. 3. To approve the Statement of Assets & Liabilities for the half year ended on 30th September 2022. 4. To approve the Statement of Cash flow for the half year ended on 30th September 2022. 5. To approve the Statement of Related Party Transactions for the half year ended on 30th September 2022. 6. Any other business with the permission of the chair. We request you to kindly take this information on record. This is to inform you that the Fourth Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2022-2023 held on Friday, 28th October, 2022 at 301 E-Square, Subhash Road, Vile Parle East, Mumbai 400057 approved the following: 1) Approved Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30th September, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Report issued by the Statutory Auditors of the Company. 2) Approved Cash Flow Statement for the half year ended on 30th September, 2022. 3) Approved Statement of Assets & Liabilities for the half year ended on 30th September, 2022. The aforesaid results are also being disseminated on Company''s website at www.nglfinechem.com. The meeting of the Board of Directors commenced at 5.00 p.m. and concluded at 6.30 p.m. Kindly take the same on your record. (As Per BSE Announcement Dated on 28.10.2022)
27-Jul-2022	10-Aug-2022	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve This is to inform you that the third Board Meeting for the financial year 2022-23 of the Board of Directors of NGL Fine-Chem Limited will be held on Wednesday 10th August 2022 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the unaudited Standalone Financial Results for the quarter ended on 30th June 2022. 2. To approve the unaudited Consolidated Financial Results for the quarter ended on 30th June 2022. 3. Any other business with the permission of the chair. We request you to kindly take this information on record. This is to inform you that the Third Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2022-2023 held on Wednesday, 10th August, 2022 at 301 E-Square, Subhash Road, Vile Parle East, Mumbai 400057 approved the following: 1) Approved Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Report issued by the Statutory Auditors of the Company. 2) Noted resignation of Mr. K.V. Subramanian (DIN: 07842700) as an Independent Director of the Company w.e.f. closer of business hours of 10th August, 2022. (Copy of the resignation letter is enclosed herewith.) The aforesaid results are also being disseminated on Company''s website at www.nglfinechem.com. The meeting of the Board of Directors commenced at 5.00 p.m. and concluded at 7.10 p.m. Kindly take the same on your record. (As Per BSE Announcement dated on 10.08.2022)
30-Jun-2022	30-Jun-2022	Change in Auditors	Pursuant to Regulation 30 the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform that the shareholders in their meeting held on 30th June, 2022, approved appointment of M/s. Manek & Associates, Chartered Accountants (FRN: 0126679W) as Statutory Auditors of the Company for a term of 5 years. Kindly take the same on your record
22-Jun-2022	22-Jun-2022	Change in Auditors	Pursuant to Regulation 30 the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform that the Board of Directors in their meeting held on Wednesday 22nd June, 2022, approved the appointment of M/s. Rach & Associates, Chartered Accountants (FRN: 140247W), Mumbai, as Internal Auditor of the Company for the F.Y. 2022-23. Further, disclosures required pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Regulations and SEBI Circular CIR/CFD/CMD/4/2015 dated 09th September, 2015 is enclosed as Annexure - I. Kindly take the same on your record.
25-Apr-2022	02-May-2022	Quarterly Results	NGL FINE-CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2022 inter alia to consider and approve This is to inform you that the first Board Meeting for the f y 2022-23 of the Board of Directors of NGL Fine-Chem Limited will be held on Monday 2nd May 2022 at the Registered Office of the Company at 301 E-Square Subhash Road Vile Parle East Mumbai 400057 to transact the following business: 1. To approve the Standalone Audited Balance Sheet as on 31st March 2022 the Statement of Profit & Loss Cash Flow Statement and statement of change in equity for the year ended on 31st March 2022 together with the schedules thereon. 2. To approve the Consolidated Audited Balance Sheet as on 31st March 2022 the Statement of Profit & Loss Cash Flow Statement and Statement of change in equity for the year ended on 31st March 2022 together with the schedules thereon. 3. To take on record the Auditors Report for the Financial Year 2021-2022. 4. To approve the Audited Standalone Financial Results for the quarter and year ended on 31st March 2022. 5. To approve the Audited Consolidated Fina This is to inform you that the First Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2022-2023 held on Monday, 2nd May, 2022 at 301 E-Square, Subhash Road, Vile Parle East, Mumbai 400057 approved the following: 1. Audited Financial Results (Standalone& Consolidated) along with Statutory Auditor's Report for the quarter and year ended on 31st March, 2022 pursuant to Regulation 33 of SEBI (Lg Obligation & Disclosure Requirements) Regulations, 2015. 2. Statement of Assets & Liabilities (Standalone & Consolidated) as on 31st March, 2022. 3. Recommendation of final Dividend of Rs.1.75/- per fully paid up equity share of Rs.5/- each for the financial year ended on 31st March, 2022. 4. Notice of the ensuing Annual General Meeting along with Director's Report for the financial year 2021-22. 5. The venue, day, date and time of 41st Annual General Meeting to be held on Thursday, 30th June, 2022 through Video Conferencing (VC) or Other Audio Visual Means (OAVM). This is to inform you that the First Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2022-2023 held on Monday, 2nd May, 2022 at 301 E-Square, Subhash Road, Vile Parle East, Mumbai 400057 approved the following: 1. Audited Financial Results (Standalone& Consolidated) along with Statutory Auditor's Report for the quarter and year ended on 31st March, 2022 pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015. 2. Statement of Assets & Liabilities (Standalone & Consolidated) as on 31st March, 2022. 3. Recommendation of final Dividend of Rs.1.75/- per fully paid up equity share of Rs.5/- each for the financial Appointed M/s. Manek & Associates, Chartered Accountants (FRN: 0126679W as Statutory Auditors of the Company for a term of 5 years. Pursuant to Regulation 30 the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform that the Board of Directors in their meeting held on 2nd May, 2022: 1) Approved appointment of M/s. Manek & Associates, Chartered Accountants (FRN: 0126679W as Statutory Auditors of the Company for a term of 5 years. 2) Approved appointment of HSPN & Associates LLP, Company Secretaries as the Secretarial Auditors of the Company for the financial year 2022-2023. Kindly take the same on your record. (As Per BSE Announcement Dated on 02.05.2022)

1 2

LOGIN HERE

NGL Fine Chem Ltd

Board Meeting